Studies of the genotype-phenotype correlation have revealed that PKD patients with PRRT2 mutations tend to present with an earlier onset, a longer attack duration, the choreoathetosis phenotype, bilateral limb involvement, and more forms of dyskinesia than patients without PRRT2 mutations [8, 13, 19]. The gene discussed is PRRT2; the disease is drug-induced dyskinesia.